A randomized multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3)

T.S. Waddell, I. Chau, Y. Barbachano, D.G. de Castro, A. Wotherspoon, C. Saffery, G.W. Middleton, J. Wadsley, D.R. Ferry, W. Mansoor, T.D.L. Crosby, F.Y. Coxon, D. Smith, J.S. Waters, T. Iveson, S. Falk, S. Slater, A.F.C. Okines, D. Cunningham

Research output: Contribution to conferenceOther contribution to conferencepeer-review

Cite this